We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Ingevity
NGVT
$2.55B
| $16.5M | 0.02% |
356,907
+303,073
| +563% | +$12.8M |
|
|
FGP
627
DELISTED
Ferrellgas Partners, L.P.
FGP
| $16.4M | 0.02% |
1,409,300
-1,859,734
| -57% | -$34.8M |
|
628
Acacia Research
ACTG
$450M
| $16.3M | 0.02% |
2,500,000
| – | – |
|
|
LOGM
629
DELISTED
LogMein, Inc.
LOGM
| $16.3M | 0.02% |
+180,062
| New | +$14.4M |
|
|
RDUS
630
DELISTED
Radius Health, Inc.
RDUS
| $16.3M | 0.02% |
300,800
-57,120
| -16% | -$2.9M |
|
631
Wabtec
WAB
$51.1B
| $16.3M | 0.02% |
199,096
-244,446
| -55% | -$17.9M |
|
632
Hilton Worldwide
HLT
$74B
| $16M | 0.02% |
232,615
+46,737
| +25% | +$3.3M |
|
633
Idexx Laboratories
IDXX
$42.9B
| $15.9M | 0.02% |
141,426
+138,640
| +4,976% | +$14.6M |
|
|
GRUB
634
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $15.9M | 0.02% |
+184,945
| New | +$13.9M |
|
635
B&G Foods
BGS
$285M
| $15.8M | 0.02% |
320,334
-17,928
| -5% | -$862K |
|
636
Cintas
CTAS
$82.4B
| $15.7M | 0.02% |
556,264
+6,504
| +1% | +$178K |
|
637
AAR Corp
AIR
$5.15B
| $15.6M | 0.02% |
497,855
-81,606
| -14% | -$2.08M |
|
638
BorgWarner
BWA
$13.2B
| $15.5M | 0.02% |
501,112
+1,061
| +0.2% | +$31.3K |
|
639
Ares Management
ARES
$28.5B
| $15.5M | 0.02% |
888,054
+4,135
| +0.5% | +$71.1K |
|
640
KBR
KBR
$4.68B
| $15.3M | 0.02% |
1,013,771
+966,988
| +2,067% | +$14.2M |
|
|
ISCA
641
DELISTED
International Speedway Corp
ISCA
| $15.3M | 0.02% |
458,965
+12,100
| +3% | +$410K |
|
642
Aecom
ACM
$9.07B
| $15.3M | 0.02% |
515,845
-142,139
| -22% | -$4.58M |
|
|
BETR
643
DELISTED
Amplify Snack Brands, Inc.
BETR
| $15.2M | 0.02% |
940,650
+62,840
| +7% | +$983K |
|
644
Evolent Health
EVH
$475M
| $15.2M | 0.02% |
+618,210
| New | +$14.5M |
|
|
VWR
645
DELISTED
VWR Corporation
VWR
| $15.1M | 0.02% |
534,037
-55,224
| -9% | -$1.6M |
|
|
RIC
646
DELISTED
Richmont Mines Inc.
RIC
| $15.1M | 0.02% |
1,500,000
-1,282,300
| -46% | -$12.8M |
|
647
TAL Education Group
TAL
$5.71B
| $15.1M | 0.02% |
1,278,000
+4,560
| +0.4% | +$48.1K |
|
|
SPNC
648
DELISTED
Spectranetics Corp
SPNC
| $15.1M | 0.02% |
601,406
-283,605
| -32% | -$6.62M |
|
649
IQVIA
IQV
$34.7B
| $15.1M | 0.02% |
185,911
| – | – |
|
650
Global Payments
GPN
$22.1B
| $15.1M | 0.02% |
196,312
-35,361
| -15% | -$2.66M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.